Calmodulin content in human brain tumors.
Using a radioimmunoassay method, the particulate and soluble calmodulin levels were determined in biopsied specimens from normal human brain and from various human brain tumors. Both in normal and pathological tissues the major portion of calmodulin was revealed in the cytosol. The chromatographic elution profiles of calmodulin obtained from soluble and particulate fractions of the same specimen were identical, thus suggesting an identity of the supernatant and particulate form of calmodulin. In all the examined oncotypes, the calmodulin content was lower than in normal extracts and this biochemical feature could not have been correlated with the degree of malignancy of the neoplasia. Furthermore, the translocation of calmodulin from the particles to the cytoplasm, reported in other rapidly growing tumors, lacks in human cerebral ones. Our findings indicate that in human brain oncotypes the calmodulin distribution is quite different from that found in tumors taken from other tissues, where its level is increased and a positive correlation between calmodulin concentration and growth rate of neoplastic tissue has been revealed.
D000328:Adult; D001932:Brain Neoplasms / Q000032:analysis*; D002147:Calmodulin / Q000378:metabolism*; D005260:Female; D005910:Glioma / Q000032:analysis; D006801:Humans; D008297:Male; D008527:Medulloblastoma / Q000032:analysis; D009837:Oligodendroglioma / Q000032:analysis; D011863:Radioimmunoassay; D013347:Subcellular Fractions / Q000032:analysis
D002147:Calmodulin